InvestorsObserver
×
News Home

Is Centene Corp (CNC) a Good Buy in the Healthcare Sector?

Wednesday, May 25, 2022 01:21 PM | InvestorsObserver Analysts

Mentioned in this article

Is Centene Corp (CNC) a Good Buy in the Healthcare Sector?

Centene Corp (CNC) is around the top of the Healthcare sector according to InvestorsObserver. CNC received an overall rating of 74, which means that it scores higher than 74% of stocks. Additionally, Centene Corp scored a 94 in the Healthcare sector, ranking it higher than 94% of stocks in that sector.

Overall Score - 74
CNC has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on CNC!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 74 means the stock is more attractive than 74 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Centene Corp Stock Today?

Centene Corp (CNC) stock is down -2.85% while the S&P 500 has gained 0.04% as of 1:13 PM on Wednesday, May 25. CNC is lower by -$2.48 from the previous closing price of $87.14 on volume of 1,221,949 shares. Over the past year the S&P 500 has fallen -5.85% while CNC has gained 14.47%. CNC earned $2.52 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 33.62. Click Here to get the full Stock Report for Centene Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App